Jump to navigation

Home

TVG Publications

Methods

2008

Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides

2007

Sensitivity and specificity of tritiated thymidine incorporation and ELISPOT assays in identifying antigen specific T cell immune responses

2006

Maximizing the retention of antigen specific lymphocyte function after cryopreservation

2005

PBMC cryopreservation using human serum albumin
Human tumor cell lysates as a protein source for the detection of cancer antigen specific humoral immunity
Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT assays
Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT
  • Research
    • Cancer Vaccines
    • Cancer Diagnostics
    • Immunologic Monitoring Laboratory (IML)
    • Adoptive T Cell Therapy
    • Tumor Microenvironment
    • Research Funding
  • Clinical Trials
    • Breast Cancer
    • Ovarian Cancer
    • Colon Cancer
    • Resources
    • FAQ - Clinical Trials
    • FAQ - The Immune System
    • FAQ - For Trial Participants
  • TVG In the News
  • Publications
    • Original Articles
    • Review Articles
    • Methods
    • Posters
    • Book Chapters
  • Directory
    • Principal Investigators
    • Research Staff
    • Clinical Staff
    • Administrative Staff
    • Students
    • Previous Staff Members
    • Contact Us
  • Support TVG
  • Original Articles
  • Review Articles
  • Methods
  • Posters
  • Book Chapters
Enroll in Clinical TrialsDonate NowConnect with us

Members of the Tumor Vaccine Group are faculty of UW Medicine, Seattle Cancer Care Alliance and Fred Hutchinson Cancer Research Center INTRANET   |  CONTACT US

Tumor Vaccine GroupDiscover - Translate - Cure850 Republican St., Seattle, WA 98109

Tumor Vaccine Group HomepageUW Medicine